Clinical Trials
AbbVie Announces Positive Topline Results from Phase 3 TEMPO-1 Trial Evaluating Tavapadon as a Monotherapy for Parkinson's Disease
AbbVie
PR-09-24-NI-17Sep 26, 2024
Clinical Result
Actinium Pharmaceuticals Announces Publication of Results from the Phase 3 SIERRA Trial of Iomab-B in Clinical Oncology
Actinium Pharmaceuticals, Inc.
PR-09-24-NI-09Sep 20, 2024